Postdoctoral Research Associate in X Inactivation Studies

University of Oxford

Oxford, South East England, United Kingdom

Salary: Grade 7: £32,236 - £39,609 p.a.

We are seeking to appoint a Postdoctoral Research Associate to work on a project to investigate the molecular mechanism of X chromosome inactivation. Key roles will be genome editing in mouse ES cells using CRISPR/Cas9 mutagenesis and analysis of transcriptomic and epigenomic features in wild-type and mutant ES cell lines.

Applicants should hold a PhD/DPhil, or be near completion of a PhD/DPhil in a relevant subject area and have proven ability to manage an independent research project, including experimental design, interpretation and presentation of data to colleagues and through publication. You should have a strong background and track record in the area of Developmental Epigenetics and expertise in CRISPR/Cas9 mutagenesis in ES cells, ChIP-seq and RNA-seq. Experience of performing computational analysis of epigenomics and transcriptional datasets would be advantageous but is not essential.

This full-time fixed-term post is funded by The Wellcome Trust for up to 5 months in the first instance and is based at the Department of Biochemistry, University of Oxford.

The actual starting salary offered will be based on qualifications and relevant skills acquired and will also be determined by the funding available. This is unlikely to be more than £34,189 p.a.

Further particulars, including details of how to apply, can be obtained from the document below.

The closing date for applications is 12.00 noon on Friday 4 January 2019 with interviews for shortlisted candidates to be held as soon as possible thereafter.

Please apply via recruiter’s website.

Quote Reference: University of Oxford-itox_ac-138390